# Toxys

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/toxys-b-v

- Industry: Biotechnology
- Headquarters: Leiden, Netherlands
- Website: www.toxys.com
- Latest round: Series A (Feb 18, 2016)
- Investors on record: 2

## About

Toxys B.V. is a Dutch biotech firm that specializes in in vitro toxicity screening solutions, focusing on identifying hazardous and potential carcinogenic properties of compounds during early product and drug development.Founded in 2014, Toxys B.V. is based in Leiden, Netherlands, and provides innovative solutions for toxicity testing. The company has successfully completed 2 deals, with its most recent funding round occurring on March 10, 2020, where it raised EUR 2 million from KIKK Capital and Rabobank Group, along with returning investors InnovationQuarter and Zeeland Investment Fund. Giel Hendriks serves as the CEO of the firm.Toxys specializes in in vitro toxicity screening solutions designed to identify hazardous and potential carcinogenic properties of novel compounds. Key offerings include the ToxTracker and ReproTracker assays, which help assess the genotoxic and teratogenic properties of substances. These solutions serve a wide array of clients, including large pharmaceutical firms and chemical manufacturers, in North America, Europe, and Asia, ensuring regulatory compliance while minimizing animal testing.Revenue is generated through partnerships and contracts with pharmaceutical and chemical clients who use Toxys' bespoke testing services, including ToxTracker and ReproTracker assays. The firm also provides kits for clients to conduct in-house testing, enhancing its revenue streams by catering to specific compliance needs and testing volumes of clients.In March 2020, Toxys B.V. raised EUR 2 million to support its growth initiatives. The company plans to expand its product offerings, including potential new assays and enhancements to existing products. Additionally, Toxys aims to penetrate new markets across Europe and Asia by 2023, leveraging the recent funding to bolster marketing efforts and enhance operational capabilities.

## Funding rounds

- Series A, Feb 18, 2016 — Zeeland Investment Fund, InnovationQuarter

## Investors

- Zeeland Investment Fund (https://capitalatlas.ai/funds/zeeland-investment-fund) — Series A
- InnovationQuarter (https://capitalatlas.ai/funds/innovationquarter) — Series A